The impact of cachexia on cardiorespiratory reflex control in chronic heart failure

European Heart Journal

Volumn 20, Issue 22, 1999, Pages 1667-1675

  Ponikowski, P ^a,b   Piepoli, M ^a   Chua, T P ^a   Banasiak, W ^b   Francis, D ^a   Anker, S D ^a   Coats, A J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MILITARY HOSPITAL   (Poland)

Author keywords

Cachexia; Cardiorespiratory reflex control; Heart failure; Neurohormones

Indexed keywords

ADRENALIN; NEUROHORMONE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREATHING REFLEX; CACHEXIA; CARDIOVASCULAR REFLEX; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPOXIA; MALE; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE; VAGUS NERVE; VAGUS TONE;

CACHEXIA; CHEMORECEPTORS; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; PRESSORECEPTORS; PROGNOSIS; PULMONARY VENTILATION; REFLEX; REFLEX, ABNORMAL; SURVIVAL RATE;

EID: 0033230269     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1525     Document Type: Article

References (48)

1. Katz AM, Katz PB. Diseases of heart in works of Hippocrates. Br Heart J. 24:1962;257-264.
2. Anker SD, Ponikowski P, Varney S. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 349:1997;1050-1053.
3. Anker SD, Chua TP, Ponikowski P. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 96:1997;526-534.
4. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol. 71:1993;3C-11C.
5. Mancia G, Seravalle G, Giannattasio C. Reflex cardiovascular control in congestive heart failure. Am J Cardiol. 69:1992;17G-23G.
6. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol. 22:1993;72A-84A.
7. Ponikowski P, Anker SD, Chua TP. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 79:1997;1645-1650.
8. Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol. 30:1997;1009-1014.
9. Mortara A, La Rovere MT, Pinna GD. Arterial baroreflex modulation on heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation. 96:1997;3450-3458.
10. Coats AJS, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure. Br Heart J. 72:1994;S36-S39.
11. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJS. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation. 93:1996;940-952.
12. Chua TP, Clark AL, Amadi AA, Coats AJS. The relationship between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 27:1996;650-657.
13. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 84:1991;482-492.
14. Ponikowski P, Chua TP, Piepoli M. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation. 96:1997;2586-2594.
15. Colombo R, Mazzuero G, Soffiantino F, Ardizzola M, Minuco G. A comprehensive PC solution to heart rate variability: analysis in mental stress. Comp Cardiol (IEEE). 1989;475-478.
16. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction: a prospective study. Circulation. 78:1988;816-824.
17. Chua TP, Coats AJS. The reproducibility and comparability of tests of the peripheral chemoreflex: comparing the transient hypoxic ventilatory drive test and the single-breath carbon dioxide response test in healthy subjects. Eur J Clin Invest. 25:1995;887-892.
18. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 271:1964;403-409.
19. Levine B, Kalman J, Mayer J, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
20. Poehlmann ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 121:1994;860-862.
21. Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJS. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430.
22. Otaki M. Surgical treatment of patients with cardiac cachexia: an analysis of factors affecting operative mortality. Chest. 105:1994;1347-1351.
23. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 20:1992;248-254.
24. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vaitali S, Giannattasio C, Del Bo A, Sala C, Bolla G, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 92:1995;2306-2311.
25. Sommers VK, Mark AL, Abboud FM. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest. 87:1991;1953-1957.
26. Mortara A, La Rovere MT, Signorini MG. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J. 71:1994;422-430.
27. Bernardi L, Salvucci F, Suardi R. Evidence for an intrinsic mechanism regulating heart rate variability in the transplanted and the intact heart during submaximal dynamic exercise? Cardiovasc Res. 24:1990;969-981.
28. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation. 95:1997;1449-1454.
29. Mancini DM, Walter G, Reichek N. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation. 85:1992;1364-1373.
30. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of ubiquitin-proteasome pathway. N Engl J Med. 335:1996;1897-1905.
31. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation. 69:1984;1079-1087.
32. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 81:1990;518-527.
33. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation. 85:1992;1751-1759.
34. Tibes U. Reflex inputs to the cardiovascular and respiratory centres from dynamically working canine muscles. Some evidence for involvement of group III and IV fibres. Circ Res. 41:1977;332-341.
35. Liang CS, Hood WB Jr. Afferent neural pathway in the regulation of cardiopulmonary responses to tissue hypermetabolism. Circ Res. 38:1976;209-214.
36. Piepoli M, Clark A, Coats AJS. Muscle metaboreceptors in hemodynamic, autonomic and ventilatory responses to exercise in men. J Am Physiol. 269:1995;H1428-H1436.
37. Anker SD, Swan JW, Volterrani M. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J. 18:1996;259-269.
38. Calman KC. Cancer cachexia. Br J Hosp Med. 26:1982;28-34.
39. Walsh D. Dyspnoea in advanced cancer. Lancet. 342:1993;450-451.
40. Anker SD, Coats AJS. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest. 115:1999;836-847.
41. Volterrani M, Scalvini S, Mazzuero G. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 106:1994;1432-1437.
42. Idiaquez J. Nutritional status and autonomic nervous system function. Funct Neurol. 3:1988;205-209.
43. Gould GA, Ashworth M, Lewis GTR. Are cardiovascular reflexes more commonly impaired in patients with bronchial carcinoma? Thorax. 41:1986;372-375.
44. Bruera E, Chadwick S, Fox R, Hanson J, MacDonald N. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 70:1986;1383-1387.
45. Cormack RS, Cunningham DJC, Gee JBL. The effect of carbon dioxide on the respiratory response to want of oxygen. Q J Exp Physiol. 42:1957;323-324.
46. Rebuck AS, Campbell EJM. A clinical method for assessing the ventilatory response to hypoxia. Am Rev Respir Dis. 109:1974;345-350.
47. Edelman NH, Epstein PE, Lahiri S, Cherniack NS. Ventilatory responses to transient hypoxia and hypercapnia in man. Resp Physiol. 17:1973;302-314.
48. Kronenberg R, Hamilton FN, Gabel R, Hickey R, Read DJC. Comparison of three methods for quantitating respiratory response to hypoxia in man. Resp Physiol. 16:1972;109-113.